发明名称 |
SALTS OF DASATINIB IN AMORPHOUS FORM |
摘要 |
The present invention primarily relates to salts of Dasatinib, wherein the salts are in amorphous form. The salts described herein preferably comprise a cation of a compound of formula 1;;and an anion of a second compound selected from the group consisting of glutaric acid, nicotinic acid and saccharin. The invention is further related to pharmaceutical compositions comprising such a salt. Furthermore, the invention relates to processes for preparing said salts. The invention also relates to several aspects of using said salt or pharmaceutical composition to treat a disease. |
申请公布号 |
US2016168142(A1) |
申请公布日期 |
2016.06.16 |
申请号 |
US201414906974 |
申请日期 |
2014.07.22 |
申请人 |
BASF SE |
发明人 |
HAFNER Andreas;BLATTER Fritz;SZELAGIEWICZ Martin;SIEBENHAAR Bernd;CHIODO Tiziana;HINTERMANN Tobias;SALVADOR Beate;VOSSER Marcus |
分类号 |
C07D417/12;C07C55/12;C07D213/80;C07D275/06 |
主分类号 |
C07D417/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
Ludwigshafen DE |